[ad_1]
SAN JOSE, California — Week four Fraud case of Elizabeth Holmes, founder of Theranos It lacked star power, but the jurors gave it the most detailed review ever of how the medical tests of the failed blood test attempt were rife with inaccuracies.
Inside attemptIn the first few weeks, several high-profile witnesses testified in the government’s trial against Ms. Holmes, who founded Theranos and turned it into a $9 billion company before that. it exploded amazingly. (Currently facing electronic fraud and conspiracy to commit electronic fraud 12 times.) Star witnesses included Erika Cheung, a former Theranos employee became an informant and former Secretary of Defense James Mattis, who once sat on the board of Theranos.
But this week, jurors listened to complex technical explanations of the problems with Theranos’ blood tests. Only two witnesses, both scientists, testified as prosecutors sought to show that Ms. Holmes deliberately misled investors and others in her initial record.
Here are three takeaways from the week.
A Theranos lab manager emerged as the key to the prosecution.
Joining Theranos in April 2013 as laboratory director before leaving the company in 2014, Dr. Adam Rosendorff began his deposition last week and continued on Friday. His four days on the stand so far have been the longest of any witnesses in the case. It will continue where it left off on Tuesday.
His testimony stood out because of his senior position in Theranos’ lab. While previous witnesses, including Ms. Cheung, also testified to Theranos’ failed tests, Dr. Rosendorff provided further details on various issues and patient complaints, including how a test got so inaccurate and “lost any diagnostic value.”
He also had access to Ms. Holmes and said he was aware of her concerns but was still pushing for Theranos commercial launch.
Dr. In his testimony, Rosendorff said Theranos was increasingly annoyed by the failure rate of its blood testing machines and the volume of doctor complaints about false test results before they ultimately gave up.
“The company was more about public relations and fundraising in terms of patient care,” he said.
John Carreyrou, who exposed Theranos’ problems while in The Wall Street Journal in 2015, clarified On Tuesday, Dr. He said Rosendorff was his “first and most important resource” in breaking the story.
Mr. Carreyrou, “Hats to your courage and honesty” Wrote from Twitter.
Prosecutors stressed that Theranos’ tests did not work.
The prosecution’s strategy this week focused on uncovering how Theranos’ machines routinely fail quality control tests and produce erroneous results.
Dr. An email presented during Rosendorff’s testimony described a patient who did not feel “right” since he increased his dose of anticoagulants in response to an incorrect Theranos test result.
Prosecutors said another witness who worked as a senior scientist while under contract with Celgene pharmaceutical company Theranos, Dr. They conducted Victoria Sung through a Celgene slide show. It included an analysis of Theranos’ tests that showed more unavailable results and greater fluctuations than commercially available alternatives.
In the end, Celgene cut the Theranos deal short.
The defense tried to put responsibility for the Theranos’ testing problems on the lab director.
Ms. Holmes’ lawyer, Lance Wade, spent three days this week with Dr. He interrogated Rosendorff to establish that it was the laboratory director—not his client—who was legally responsible for what had happened in Theranos’ lab.
Mr. Wade compared to Ms. Holmes, who dropped out of Stanford University in her sophomore year, Dr. He emphasized Rosendorff’s advanced scientific knowledge. Dr. Rosendorff admitted that Miss Holmes had never instructed him to report a false result.
But according to emails and statements submitted by the government, Dr. Rosendorff had raised her concerns about faulty testing and quality control failures to Ms. Holmes and other senior executives. Other email chains, Dr. It showed that Rosendorff was out of the loop with some patient complaints and testing decisions.
On Friday, Mr. Wade said doctors had been slow to respond to his complaints. He tried to undermine Rosendorff’s credibility. Mr. Wade also Rosendorff discusses jury emails between Ms. Holmes and former Theranos chief of operations Sunny Balwani, Dr. He showed it to show that they were open to Rosendorff’s concerns.
[ad_2]
Source link